Healthtech Startups

QuantuMDx develops point-of-care molecular diagnostics platforms and assays for detecting infectious diseases including sexually transmitted infections, antimicrobial resistance, respiratory viruses, and other pathogens. The company's Q-POC platform delivers rapid PCR test results in approximately 30 minutes for use in clinical, care home, and healthcare settings.

3 investors

Quell develops fitness gaming software that combines combat-based gameplay with physical exercise, helping users achieve fitness goals through interactive gaming experiences.

3 investors

Pelago provides virtual-first substance use treatment for tobacco, alcohol, opioids, cannabis, and stimulants, combining digital tools, live counseling, and medication-assisted treatment for employers and organizations.

3 investors

QV Bioelectronics develops GRACE, an implantable electric field delivery platform designed to treat aggressive cancers by delivering continuous therapeutic electric fields directly to tumor sites. The company targets oncology indications including glioblastoma, brain metastases, and pancreatic cancer.

3 investors

UCB (UCB SA/NV) is a publicly listed biopharmaceutical company focused on research and development of medicines for defined patient populations. This page presents the company's corporate governance structure, including its Board of Directors and Executive Committee.

3 investors

Radformation develops automation software for radiation oncology, including tools for deep-learning contouring, treatment planning, plan evaluation, independent calculations, treatment monitoring, billing QA, and machine QA. Its products integrate with Eclipse TPS and serve cancer clinics and medical physicists to improve plan quality, safety, and workflow efficiency.

3 investors

Radial provides mental health care through a team-based, concierge-style approach using evidence-based and newer rapid-acting treatments for conditions like depression, trauma, and OCD. The service combines psychiatry, therapy, and care navigation to simplify access to mental health treatment.

3 investors

Radiology Partners is a physician-led national radiology practice that provides diagnostic imaging services and develops AI tools and technology to support radiologists in delivering patient care. It serves patients, referring physicians, and healthcare clients across the United States.

3 investors

Railofy is a wellness and movement education platform that publishes content on health, fitness, longevity, and well-being topics for individuals seeking to optimize their physical and mental health through evidence-based practices.

3 investors

GE Healthcare provides AI-enabled medical devices and diagnostic solutions for healthcare providers worldwide, helping clinicians improve diagnostic accuracy and clinical decision-making. The company operates across medical imaging, monitoring, and healthcare IT with over 130 years of innovation history.

3 investors

A biopharmaceutical company developing therapies for neurology, immunology, and rare diseases. The page describes work focused on treating hard-to-treat conditions.

3 investors

Readcoor developed an in situ spatial transcriptomics platform using padlock probe rolling circle amplification chemistry to detect and map RNA transcripts across tissue sections, now offered as the Xenium In Situ platform. It serves researchers analyzing gene expression at subcellular resolution, including in FFPE and degraded samples.

3 investors

RealSelf is an online platform where consumers can research cosmetic and aesthetic procedures, read peer reviews with "Worth It" ratings, and view average cost information for treatments such as HydraFacial, PRP injections, and Sculptra. It serves people considering surgical and non-surgical skin rejuvenation and cosmetic treatments.

3 investors

AXO delivers personalized health protocols based on individual biology, including supplement, nutrition, and lifestyle recommendations. The platform combines user assessments, optional lab testing, and continuous refinement to serve health-conscious consumers.

3 investors

Rebel Medicine develops preclinical investigational drugs and wound care products designed to provide pain relief without opioids. The company targets postoperative and wound care patients through patented drug delivery technologies for local anesthetic applications.

3 investors

ReBio develops targeted, locally delivered therapies for ocular oncology, using its proprietary SiSu conjugate platform to program drug exposure for eye diseases. Its lead program, RBP-01, is a SiSu-conjugated PKC inhibitor for uveal melanoma delivered via intravitreal injection, with additional programs targeting retinoblastoma, glaucoma, and post-op ocular inflammation.

3 investors

ReBokeh develops assistive technology for people with vision impairments, offering modern alternatives to outdated devices like magnifiers and audio-only tools. The company serves students and professionals with visual disabilities who need solutions that preserve and enhance their residual vision.

3 investors

Recludix Pharma operates a drug discovery platform that combines custom DNA-encoded libraries (DELs), massively parallel structure-activity relationship analysis, structure-based design, and a family-wide SH2 domain screening panel. It applies this approach first to discover selective SH2 domain inhibitors for treating inflammatory diseases.

3 investors

Recornea is developing corneal implants for people with keratoconus, a condition in which the cornea progressively bulges outward. Its GROSSO Implant, currently at the pre-clinical stage, is intended to restore corneal shape and improve vision as an alternative to a full corneal transplant.

3 investors

Redi Health builds patient access and affordability programs that connect pharmaceutical manufacturers to patients through targeted approaches designed to increase medication adoption and sustained use.

3 investors

Redx is a clinical-stage biotechnology company developing small molecule targeted medicines focused on fibrotic diseases, leveraging ROCK pathway inhibitors and novel targets. The company also maintains an oncology pipeline with partnered and in-house programs for unmet medical needs.

3 investors

REEV develops intelligent wearable robotic systems, including a robotic knee orthosis and gait-analysis technology, to restore mobility for people with movement disorders. The company serves patients with neurological and mobility conditions, operating in the medical robotics and rehabilitation technology sector.

3 investors

ReflexAI provides AI-powered simulations and quality assurance tools for clinical teams to practice patient interactions and ensure adherence to care standards. The platform offers realistic roleplay scenarios and automated feedback to improve communication skills, empathy, and protocol compliance across healthcare settings.

3 investors

Regenosine develops regenerative medicine therapies for musculoskeletal and orthopedic conditions. The company leverages adenosine-based science to address inflammatory diseases and tissue healing.

3 investors